Published Data Registry

Search and Filter

Sorting: Sort the table by clicking on the header of the column to order the table by. Cycle through the orderings by clicking multiple times. The signs ▴ ▾ indicate when a column is currently used for sorting and whether it is ordered in an ascending or descending fashion.

Searching: Enter one or multiple terms separated by blank spaces into the search bar. Terms in between two quotation marks are considered one search term.

Filtering: Filter by Working Group, External ID or Number of Working Groups (individually or jointly) by selecting an element from the Filter dropdown menus.

Working Group

External ID

Number of Working Groups

Linkings

Publication Type

Peer Reviewed

show all

Title	Authors ▴	Journal	Publication year	DOI PMID
Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease	Schäffner E, Bosch-Queralt M, (...), Stassart RM	Nature Neuroscience	2023	10.1038/s41593-023-01366-9
Alpha-synuclein induces epigenomic dysregulation of glutamate signaling and locomotor pathways	Schaffner SL, Wassouf Z, (...), Kobor MS	bioRxiv	2021	10.1101/2021.06.12.448150
Alpha-synuclein overexpression induces epigenomic dysregulation of glutamate signaling and locomotor pathways	Schaffner SL, Wassouf Z, (...), Kobor MS	Human Molecular Genetics	2022	10.1093/hmg/ddac104 35567546
Two mechanisms drive pronuclear migration in mouse zygotes	Scheffler K, Uraji J, (...), Schuh M	Nature Communications	2021	10.1038/s41467-021-21020-x 33547291
Structure of RNA polymerase II pre-initiation complex at 2.9 Å defines initial DNA opening	Schilbach S, Aibara S, Dienemann C, Grabbe F, Cramer P	Cell	2021	10.1016/j.cell.2021.05.012
Yeast PIC-Mediator structure with RNA polymerase II C-terminal domain	Schilbach S, Wang H, Dienemann C, Cramer P	Proceedings of the National Academy of Sciences of the United States of America	2023	10.1073/pnas.2220542120 37014863
Tazarotene and Bexarotene Show Efficacy as In Vitro Therapeutic Agents in Multiple Sulfatase Deficiency	Schlotawa L, Matysiak K, (...), Gärtner J	Neuropediatrics	2023	10.1055/s-0043-1777171
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency	Schlotawa L, Tyka K, (...), Gärtner J	EMBO Molecular Medicine	2023	10.15252/emmm.202114837 36789546
Structure and dynamics of human cardiac fibroblast nanotubes	Schmid-Herbstritt S, Stief G, (...), Rog-Zielinska E	bioRxiv	2023	10.1101/2023.11.28.568871
Expansion of the complex genotypic and phenotypic spectrum of FGFR2-associated neurocutaneous syndromes	Schmidt J, Kaulfuß S, (...), Wollnik B	Human Genetics	2024	10.1007/s00439-023-02634-1 38265560